Target Name: CDH17
NCBI ID: G1015
Review Report on CDH17 Target / Biomarker Content of Review Report on CDH17 Target / Biomarker
CDH17
Other Name(s): Human intestinal peptide-associated transporter HPT-1 | Human peptide transporter 1 | LI-cadherin | Cadherin-17 | CDH16 | CAD17_HUMAN | Cadherin 17, transcript variant 2 | liver-intestine cadherin | CDH17 variant 2 | HPT1 | CDH17 variant 1 | human peptide transporter 1 | LI cadherin | intestinal peptide-associated transporter HPT-1 | Cadherin 17, transcript variant 1 | HPT-1 | cadherin-16 | Intestinal peptide-associated transporter HPT-1 | HPT-1 cadherin | Liver-intestine cadherin | cadherin 17 | cadherin 17, LI cadherin (liver-intestine) | Cadherin 17 | human intestinal peptide-associated transporter HPT-1

CDH17: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

CDH17 (Complement component H17) is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and hair. Its primary function is to initiate the complement system, which is a group of proteins that work together to help the immune system recognize and fight off infections. CDH17 has also been shown to play a key role in skin repair and inflammation, making it an attractive drug target and biomarker for the treatment of inflammatory diseases.

CDH17's Role in the Immune System

CDH17 is a key player in the immune system, as it helps to regulate the complement system. The complement system is a group of proteins that work together to help the immune system recognize and fight off infections. CDH17 is responsible for initiating the complement system and for regulating the activity of the other components.

One of the key functions of CDH17 is its role in the regulation of the activity of the C5b molecule. C5b is a protein that is expressed in the immune system and plays a key role in the development of antibodies, which are the body's primary defense against infections. CDH17 helps to regulate the activity of C5b by ensuring that it is properly translated and activated.

In addition to its role in regulating the complement system, CDH17 has also been shown to play a key role in the regulation of skin repair and inflammation. For example, studies have shown that CDH17 plays a key role in the regulation of skin repair after injury or trauma. When the skin is injured or damaged, CDH17 helps to regulate the production of cells that are involved in skin repair, such as the activation and proliferation of stem cells.

CDH17's Role in Inflammatory Diseases

CDH17 has also been shown to play a key role in the regulation of inflammatory diseases. For example, studies have shown that CDH17 plays a key role in the regulation of inflammation in the skin. When the body is exposed to an infection or irritant, CDH17 helps to regulate the production of cells that are involved in inflammation, such as neutrophils.

In addition to its role in inflammation, CDH17 has also been shown to play a key role in the regulation of pain. For example, studies have shown that CDH17 plays a key role in the regulation of pain when the body is exposed to pain-inducing stimuli. When the body is exposed to pain-inducing stimuli, CDH17 helps to regulate the production of cells that are involved in pain signaling, such as neurons.

CDH17 as a Potential Drug Target

CDH17's role in the immune system and skin repair make it an attractive drug target for the treatment of inflammatory diseases. Many drugs that are currently used to treat inflammatory diseases, such as arthritis and skin infections, work by targeting different components of the immune system or the complement system. By targeting CDH17, these drugs could potentially have more targeted and effective effects on inflammatory diseases.

In addition to its potential as a drug target, CDH17 is also a potential biomarker for the treatment of inflammatory diseases. By measuring the levels of CDH17 in the body, doctors could potentially use CDH17 as a marker to track the effectiveness of different treatments for inflammatory diseases. This could help to improve the accuracy and effectiveness of personalized medicine.

Conclusion

CDH17 is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and hair. Its primary function is to initiate the complement system, which is a group of proteins that work together to help the immune system recognize and fight off infections. In addition to its role in the immune system, CDH17 has also been shown to play a key role in the regulation of skin repair and inflammation. As a potential drug target and biomarker for the treatment of inflammatory diseases, CDH17 is an attractive target for further research and development.

Protein Name: Cadherin 17

Functions: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. LI-cadherin may have a role in the morphological organization of liver and intestine. Involved in intestinal peptide transport

The "CDH17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CDH17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CDH18 | CDH19 | CDH2 | CDH20 | CDH22 | CDH23 | CDH24 | CDH26 | CDH3 | CDH4 | CDH5 | CDH6 | CDH7 | CDH8 | CDH9 | CDHR1 | CDHR18P | CDHR2 | CDHR3 | CDHR4 | CDHR5 | CDIN1 | CDIP1 | CDIPT | CDIPTOSP | CDK1 | CDK10 | CDK11A | CDK11B | CDK12 | CDK13 | CDK14 | CDK15 | CDK16 | CDK17 | CDK18 | CDK19 | CDK2 | CDK20 | CDK2AP1 | CDK2AP2 | CDK2AP2P2 | CDK2AP2P3 | CDK3 | CDK4 | CDK5 | CDK5R1 | CDK5R2 | CDK5RAP1 | CDK5RAP2 | CDK5RAP3 | CDK6 | CDK6-AS1 | CDK7 | CDK8 | CDK9 | CDKAL1 | CDKL1 | CDKL2 | CDKL3 | CDKL4 | CDKL5 | CDKN1A | CDKN1B | CDKN1C | CDKN2A | CDKN2A-DT | CDKN2AIP | CDKN2AIPNL | CDKN2AIPNLP1 | CDKN2B | CDKN2B-AS1 | CDKN2C | CDKN2D | CDKN3 | CDNF | CDO1 | CDON | CDPF1 | CDR1 | CDR2 | CDR2L | CDRT15 | CDRT15L2 | CDRT4 | CDRT7 | CDS1 | CDS2 | CDSN | CDT1 | CDV3 | CDX1 | CDX2 | CDX4 | CDY1 | CDY1B | CDY2A | CDYL | CDYL2 | CEACAM1